I don't understand the sovereignty many here see in neu retts treatment . I'm aware of at least four other biotechs product development on retts syndrome with at this stage some of which appears promising . Surely this competitive aspect would play a part in the mitigation of the price .
- Forums
- ASX - By Stock
- NEU
- Share Price
Share Price, page-11815
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$13.36 |
Change
-0.450(3.26%) |
Mkt cap ! $1.726B |
Open | High | Low | Value | Volume |
$13.82 | $13.91 | $13.32 | $3.664M | 269.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4 | $14.69 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.03 | 1364 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 116 | 13.330 |
4 | 912 | 13.320 |
4 | 691 | 13.310 |
7 | 4676 | 13.300 |
5 | 2703 | 13.290 |
Price($) | Vol. | No. |
---|---|---|
13.340 | 598 | 11 |
13.350 | 1777 | 8 |
13.360 | 277 | 4 |
13.370 | 228 | 2 |
13.380 | 230 | 2 |
Last trade - 15.59pm 11/09/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |